The robustness of these results is nicely demonstrated by our lead miRNA, miR-132, which has been validated to be associated with AD in prior targeted studies [12, 13, 39] and for which selected putative target genes have been evaluated in brain samples, including EP300 and SIRT1 [12, 14]. The gene discussed is SIRT1; the disease is Alzheimer disease.